SBI Securities’s Quince Therapeutics QNCX Stock Holding History

SBI Securities’s Portfolio QNCX Stock Details QNCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$14	–	4179
2026 Q1	$14	Buy	+1	New	+$201	﹤0.01%	3812
2025 Q4	–	Hold	0	–	–	–	3126
2025 Q3	–	Hold	0	–	–	–	3450
2025 Q2	–	Hold	0	–	–	–	3462
2025 Q1	–	Hold	0	–	–	–	3449
2024 Q4	–	Hold	0	–	–	–	3364

Other funds holding QNCX

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

SBI Securities's QNCX Position: Q2 2026 in Review

SBI Securities sold out of Quince Therapeutics (QNCX) in Q2 2026, closing a stake of 1 share — an estimated $14 sold.

SBI Securities first reported a position in QNCX in Q1 2026 and held it in 1 quarter. The position peaked at $14 in Q1 2026. 1 fund tracked by Wall St. Rank holds QNCX as of Q2 2026.

SBI Securities reported no remaining Quince Therapeutics position as of Q2 2026 after selling out during the quarter.
SBI Securities sold 1 Quince Therapeutics share in Q2 2026, an estimated $14.
SBI Securities first reported a position in Quince Therapeutics in Q1 2026 and held it in 1 quarter.
SBI Securities's Quince Therapeutics position peaked at $14 in Q1 2026.
1 fund tracked by Wall St. Rank held Quince Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.